Hemodynamic ABI Monitor

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 6, 2024

Primary Completion Date

December 6, 2026

Study Completion Date

December 6, 2026

Conditions
Traumatic Brain Injury (TBI)Intracerebral Hemorrhage
Trial Locations (1)

60637

RECRUITING

University of Chicago, Chicago

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

University of Chicago

OTHER

NCT06725108 - Hemodynamic ABI Monitor | Biotech Hunter | Biotech Hunter